Rankings
▼
Calendar
EOLS Q4 2021 Earnings — Evolus, Inc. Revenue & Financial Results | Market Cap Arena
EOLS
Evolus, Inc.
$353M
Q4 2021 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$35M
+68.4% YoY
Gross Profit
$19M
54.3% margin
Operating Income
-$18M
-52.0% margin
Net Income
-$18M
-52.4% margin
EPS (Diluted)
$-0.33
QoQ Revenue Growth
+29.9%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$257M
Total Liabilities
$176M
Stockholders' Equity
$82M
Cash & Equivalents
$146M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$35M
$21M
+68.4%
Gross Profit
$19M
$13M
+41.5%
Operating Income
-$18M
-$108M
+83.3%
Net Income
-$18M
-$111M
+83.6%
Revenue Segments
Product
$35M
100%
← FY 2021
All Quarters
Q1 2022 →